Suppr超能文献

人类卵巢衰老:延长生殖寿命的潜在策略。

Ovarian aging in humans: potential strategies for extending reproductive lifespan.

机构信息

Postgraduate Program in Medical Sciences, University of Fortaleza (UNIFOR), Fortaleza, CE, 60.811-905, Brazil.

Nutrition College, Federal University of Pelotas (UFPel), Pelotas, RS, 96010-610, Brazil.

出版信息

Geroscience. 2023 Aug;45(4):2121-2133. doi: 10.1007/s11357-023-00768-8. Epub 2023 Mar 13.

Abstract

Ovarian reserve is a term used to estimate the total number of immature follicles present in the ovaries. Between birth and menopause, there is a progressive decrease in the number of ovarian follicles. Ovarian aging is a continuous physiological phenomenon, with menopause being the clinical mark of the end of ovarian function. Genetics, measured as family history for age at the onset of menopause, is the main determinant. However, physical activity, diet, and lifestyle are important factors that can influence the age of menopause. The low estrogen levels after natural or premature menopause increased the risk for several diseases, resulting in increased mortality risk. Besides that, the decreasing ovarian reserve is associated to reduced fertility. In women with infertility undergoing in vitro fertilization, reduced markers of ovarian reserve, including antral follicular count and anti-Mullerian hormone, are the main indicators of reduced chances of becoming pregnant. Therefore, it becomes clear that the ovarian reserve has a central role in women's life, affecting fertility early in life and overall health later in life. Based on this, the ideal strategy for delaying ovarian aging should have the following characteristics: (1) be initiated in the presence of good ovarian reserve; (2) maintained for a long period; (3) have an action on the dynamics of primordial follicles, controlling the rate of activation and atresia; and (4) safe use in pre-conception, pregnancy, and lactation. In this review, we therefore discuss some of these strategies and its feasibility for preventing a decline in the ovarian reserve.

摘要

卵巢储备是一个用来估计卵巢中未成熟卵泡总数的术语。在出生到绝经期间,卵巢卵泡的数量逐渐减少。卵巢衰老(ovarian aging)是一个连续的生理现象,绝经是卵巢功能结束的临床标志。遗传因素(measured as family history for age at the onset of menopause)被认为是主要决定因素。然而,身体活动、饮食和生活方式是影响绝经年龄的重要因素。自然或过早绝经后雌激素水平降低会增加多种疾病的风险,从而增加死亡风险。此外,卵巢储备减少与生育能力下降有关。在接受体外受精的不孕妇女中,卵巢储备减少的标志物,包括窦卵泡计数和抗苗勒管激素,是怀孕机会减少的主要指标。因此,很明显,卵巢储备在女性生活中起着核心作用,影响着生命早期的生育能力和生命后期的整体健康。基于这一点,延迟卵巢衰老的理想策略应该具有以下特点:(1)在良好的卵巢储备存在的情况下开始;(2)长期维持;(3)对原始卵泡的动力学有作用,控制激活和闭锁的速度;(4)在受孕前、妊娠和哺乳期安全使用。在这篇综述中,我们因此讨论了一些这些策略及其预防卵巢储备下降的可行性。

相似文献

1
Ovarian aging in humans: potential strategies for extending reproductive lifespan.
Geroscience. 2023 Aug;45(4):2121-2133. doi: 10.1007/s11357-023-00768-8. Epub 2023 Mar 13.
2
Reproductive potential in the older woman.
Fertil Steril. 1986 Dec;46(6):989-1001. doi: 10.1016/s0015-0282(16)49869-9.
3
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Hum Reprod Update. 2014 Sep-Oct;20(5):688-701. doi: 10.1093/humupd/dmu020. Epub 2014 May 12.
4
Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Hum Reprod. 2015 Oct;30(10):2364-75. doi: 10.1093/humrep/dev197. Epub 2015 Aug 25.
5
The physiology and clinical utility of anti-Mullerian hormone in women.
Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14.
7
Advanced reproductive age and fertility.
J Obstet Gynaecol Can. 2011 Nov;33(11):1165-1175. doi: 10.1016/S1701-2163(16)35087-3.
8
Reproductive Longevity and Aging: Geroscience Approaches to Maintain Long-Term Ovarian Fitness.
J Gerontol A Biol Sci Med Sci. 2021 Aug 13;76(9):1551-1560. doi: 10.1093/gerona/glaa204.
10
Ovarian aging: mechanisms and clinical consequences.
Endocr Rev. 2009 Aug;30(5):465-93. doi: 10.1210/er.2009-0006. Epub 2009 Jul 9.

引用本文的文献

3
Mesenchymal Stem Cells: A Therapeutic Approach in Fertility Restoration in Premature Ovarian Insufficiency.
Stem Cell Rev Rep. 2025 Oct;21(7):2089-2102. doi: 10.1007/s12015-025-10944-2. Epub 2025 Aug 1.
4
Role of AMP-Activated Protein Kinase (AMPK) in Female Reproduction: A Review.
Int J Mol Sci. 2025 Jul 16;26(14):6833. doi: 10.3390/ijms26146833.
6
Ovarian remodeling and aging-related chronic inflammation and fibrosis in the mammalian ovary.
J Ovarian Res. 2025 Jun 18;18(1):133. doi: 10.1186/s13048-025-01715-1.
7
The risk factors, pathogenesis and treatment of premature ovarian insufficiency.
J Ovarian Res. 2025 Jun 18;18(1):134. doi: 10.1186/s13048-025-01714-2.
8
Germ cells and the aging niche: a systems approach to reproductive longevity.
J Assist Reprod Genet. 2025 May 29. doi: 10.1007/s10815-025-03518-1.

本文引用的文献

1
piRNAs regulate a Hedgehog germline-to-soma pro-aging signal.
Nat Aging. 2023 Jan;3(1):47-63. doi: 10.1038/s43587-022-00329-2. Epub 2023 Jan 9.
2
Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
Geroscience. 2023 Jun;45(3):1775-1790. doi: 10.1007/s11357-023-00728-2. Epub 2023 Jan 17.
3
Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.
Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:60-63. doi: 10.1016/j.ejogrb.2022.11.001. Epub 2022 Nov 4.
6
Ovarian tissue bank for fertility preservation and anti-menopause hormone replacement.
Front Endocrinol (Lausanne). 2022 Sep 9;13:950297. doi: 10.3389/fendo.2022.950297. eCollection 2022.
7
The use of non-model Drosophila species to study natural variation in TOR pathway signaling.
PLoS One. 2022 Sep 22;17(9):e0270436. doi: 10.1371/journal.pone.0270436. eCollection 2022.
9
Polycystic ovary syndrome.
Lancet Diabetes Endocrinol. 2022 Sep;10(9):668-680. doi: 10.1016/S2213-8587(22)00163-2. Epub 2022 Aug 4.
10
The 2022 hormone therapy position statement of The North American Menopause Society.
Menopause. 2022 Jul 1;29(7):767-794. doi: 10.1097/GME.0000000000002028.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验